Development of human embryonic stem cell therapies for age-related macular degeneration

Trends in Neurosciences

Volumn 36, Issue 7, 2013, Pages 385-395

  Carr, Amanda Jayne F ^a   Smart, Matthew J K ^a   Ramsden, Conor M ^a,b   Powner, Michael B ^a   da Cruz, Lyndon ^b   Coffey, Peter J ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

age related macular degeneration; cellular therapy; human embryonic stem cells; induced pluripotent stem cells; retinal pigment epithelium; transplantation

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MELANIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; ORTHODENTICLE HOMOLOG 2 PROTEIN; PROTEIN ZO1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX6; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

BRACHYTHERAPY; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; HUMAN; NONHUMAN; PHENOTYPE; PHOTODYNAMIC THERAPY; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; STEM CELL TRANSPLANTATION; VISION; VISUAL ACUITY;

AGE OF ONSET; ANIMALS; EMBRYONIC STEM CELLS; HUMANS; MACULAR DEGENERATION; RETINAL PIGMENT EPITHELIUM; STEM CELL TRANSPLANTATION;

EID: 84879787319     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2013.03.006     Document Type: Review

References (109)

1. de Jong P.T.V.M. Age-related macular degeneration. N. Engl. J. Med. 2006, 355:1474-1485.
2. Rizzolo L.J., et al. Integration of tight junctions and claudins with the barrier functions of the retinal pigment epithelium. Prog. Retin. Eye Res. 2011, 30:296-323.
3. Strauss O. The retinal pigment epithelium in visual function. Physiol. Rev. 2005, 85:845-881.
4. Sparrow J.R., et al. The retinal pigment epithelium in health and disease. Curr. Mol. Med. 2010, 10:802-823.
5. Kinnunen K., et al. Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration. Acta Ophthalmol. 2012, 90:299-309.
6. Martin D.F., et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 2011, 364:1897-1908.
7. Heier J.S., et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 2012, 119:2537-2548.
8. da Cruz L., et al. RPE transplantation and its role in retinal disease. Prog. Retin. Eye Res. 2007, 26:598-635.
9. Binder S., et al. Transplantation of the RPE in AMD. Prog. Retin. Eye Res. 2007, 26:516-554.
10. Machemer R., Steinhorst U.H. Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration?. Graefes Arch. Clin. Exp. Ophthalmol. 1993, 231:635-641.
11. de Juan E., et al. Translocation of the retina for management of subfoveal choroidal neovascularization II: a preliminary report in humans. Am. J. Ophthalmol. 1998, 125:635-646.
12. Lai J.C., et al. Visual outcomes following macular translocation with 360-degree peripheral retinectomy. Arch. Ophthalmol. 2002, 120:1317-1324.
13. Chen F.K., et al. Long-term outcomes following full macular translocation surgery in neovascular age-related macular degeneration. Br. J. Ophthalmol. 2010, 94:1337-1343.
14. Takeuchi K., et al. Visual function 5 years or more after macular translocation surgery for myopic choroidal neovascularisation and age-related macular degeneration. Eye 2011, 26:51-60.
15. Gelisken F., et al. Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT). Graefes Arch. Clin. Exp. Ophthalmol. 2007, 245:1085-1095.
16. Falkner-Radler C.I., et al. Human retinal pigment epithelium (RPE) transplantation: outcome after autologous RPE-choroid sheet and RPE cell-suspension in a randomised clinical study. Br. J. Ophthalmol. 2011, 95:370-375.
17. MacLaren R.E., et al. Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration. Ophthalmology 2007, 114:561-570.
18. Joussen A.M., et al. Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am. J. Ophthalmol. 2006, 142:17-30.
19. Joussen A.M. How complete is successful? 'Autologous retinal pigment epithelium and choriod translocation in patients with exsudative age-related macular degeneration: a short-term follow-up' by Jan van Meurs and P. R. van Biesen. Graefes Arch. Clin. Exp. Ophthalmol. 2003, 241:966-967.
20. Binder S., et al. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest. Ophthalmol. Vis. Sci. 2004, 45:4151-4160.
21. Peyman G.A., et al. A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surg. 1991, 22:102-108.
22. Gal A., et al. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat. Genet. 2000, 26:270-271.
23. Bok D., Hall M.O. The role of the pigment epithelium in the etiology of inherited retinal dystrophy in the rat. J. Cell Biol. 1971, 49:664-682.
24. Li L.X., Turner J.E. Inherited retinal dystrophy in the RCS rat: prevention of photoreceptor degeneration by pigment epithelial cell transplantation. Exp. Eye Res. 1988, 47:911-917.
25. Lawrence J.M., et al. Schwann cell grafting into the retina of the dystrophic RCS rat limits functional deterioration. Royal College of Surgeons. Invest. Ophthalmol. Vis. Sci. 2000, 41:518-528.
26. Little C.W., et al. Correlates of photoreceptor rescue by transplantation of human fetal RPE in the RCS rat. Exp. Neurol. 1998, 149:151-160.
27. Seaton A.D., et al. A primary role for RPE transplants in the inhibition and regression of neovascularization in the RCS rat. Invest. Ophthalmol. Vis. Sci. 1994, 35:162-169.
28. McGill T.J., et al. Transplantation of human central nervous system stem cells: neuroprotection in retinal degeneration. Eur. J. Neurosci. 2012, 35:468-477.
29. Lund R.D., et al. Subretinal transplantation of genetically modified human cell lines attenuates loss of visual function in dystrophic rats. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:9942-9947.
30. Wang S., et al. Grafting of ARPE-19 and Schwann cells to the subretinal space in RCS rats. Invest. Ophthalmol. Vis. Sci. 2005, 46:2552-2560.
31. Coffey P.J., et al. Long-term preservation of cortically dependent visual function in RCS rats by transplantation. Nat. Neurosci. 2002, 5:53-56.
32. Girman S.V., et al. Cortical visual functions can be preserved by subretinal RPE cell grafting in RCS rats. Vision Res. 2003, 43:1817-1827.
33. Gias C., et al. Preservation of visual cortical function following retinal pigment epithelium transplantation in the RCS rat using optical imaging techniques. Eur. J. Neurosci. 2007, 25:1940-1948.
34. Dunn K.C., et al. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp. Eye Res. 1996, 62:155-169.
35. Alge C.S., et al. Comparative proteome analysis of native differentiated and cultured dedifferentiated human RPE cells. Invest. Ophthalmol. Vis. Sci. 2003, 44:3629-3641.
36. Vinores S.A., et al. Class III beta-tubulin in human retinal pigment epithelial cells in culture and in epiretinal membranes. Exp. Eye Res. 1995, 60:385-400.
37. Thomson J.A., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
38. Amit M., et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 2000, 227:271-278.
39. Reubinoff B.E., et al. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 2000, 18:399-404.
40. Kawasaki H., et al. Generation of dopaminergic neurons and pigmented epithelia from primate ES cells by stromal cell-derived inducing activity. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:1580-1585.
41. Haruta M., et al. In vitro and in vivo characterization of pigment epithelial cells differentiated from primate embryonic stem cells. Invest. Ophthalmol. Vis. Sci. 2004, 45:1020-1025.
42. Hirano M., et al. Generation of structures formed by lens and retinal cells differentiating from embryonic stem cells. Dev. Dyn. 2003, 228:664-671.
43. Klimanskaya I., et al. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 2004, 6:217-245.
44. Lund R.D., et al. Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells 2006, 8:189-199.
45. Vugler A., et al. Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp. Neurol. 2008, 214:347-361.
46. Vugler A., et al. Embryonic stem cells and retinal repair. Mech. Dev. 2007, 124:807-829.
47. Stover A.E., Schwartz P.H. The generation of embryoid bodies from feeder-based or feeder-free human pluripotent stem cell cultures. Methods Mol. Biol. 2011, 767:391-398.
48. Park U.C., et al. Subretinal transplantation of putative retinal pigment epithelial cells derived from human embryonic stem cells in rat retinal degeneration model. Clin. Exp. Reprod. Med. 2011, 38:216-221.
49. Meyer J.S., et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:16698-16703.
50. Watanabe K., et al. Directed differentiation of telencephalic precursors from embryonic stem cells. Nat. Neurosci. 2005, 8:288-296.
51. Ikeda H., et al. Generation of Rx+/Pax6+ neural retinal precursors from embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11331-11336.
52. Osakada F., et al. Stepwise differentiation of pluripotent stem cells into retinal cells. Nat. Protoc. 2009, 4:811-824.
53. Chow R.L., Lang R.A. Early eye development in vertebrates. Annu. Rev. Cell Dev. Biol. 2001, 17:255-296.
54. Graw J. Eye development. Curr. Top. Dev. Biol. 2010, 90:343-386.
55. Sakami S., et al. Activin signaling limits the competence for retinal regeneration from the pigmented epithelium. Mech. Dev. 2008, 125:106-116.
56. Martinez-Morales J.R., et al. Eye development: a view from the retina pigmented epithelium. Bioessays 2004, 26:766-777.
57. Jaffe G.J., et al. Activin expression by cultured human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 1994, 35:2924-2931.
58. Fuhrmann S., et al. Extraocular mesenchyme patterns the optic vesicle during early eye development in the embryonic chick. Development 2000, 127:4599-4609.
59. Idelson M., et al. Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 2009, 5:396-408.
60. Hongisto H., et al. Low level of activin A secreted by fibroblast feeder cells accelerates early stage differentiation of retinal pigment epithelial cells from human pluripotent stem cells. Stem Cell Discov. 2012, 2:180-190.
61. Vaajasaari H., et al. Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells. Mol. Vis. 2011, 17:558-575.
62. Rowland T.J., et al. Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins. J. Tissue Eng. Regen. Med. 2012, 10.1002/term.1458.
63. Maminishkis A., et al. Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest. Ophthalmol. Vis. Sci. 2006, 47:3612-3624.
64. Buchholz D.E., et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 2009, 27:2427-2434.
65. Liu Y., et al. Zeb1 represses Mitf and regulates pigment synthesis, cell proliferation and epithelial morphology. Invest. Ophthalmol. Vis. Sci. 2009, 50:5080-5088.
66. Liao J.L., et al. Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells. Hum. Mol. Genet. 2010, 19:4229-4238.
67. Osakada F., et al. Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat. Biotechnol. 2008, 26:215-224.
68. Lu B., et al. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 2009, 27:2126-2135.
69. Lamba D.A., Reh T.A. Microarray characterization of human embryonic stem cell-derived retinal cultures. Invest. Ophthalmol. Vis. Sci. 2011, 52:4897-4906.
70. Carr A.J., et al. Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay. Mol. Vis. 2009, 15:283-295.
71. Onnela N., et al. Electric impedance of human embryonic stem cell-derived retinal pigment epithelium. Med. Biol. Eng. Comput. 2012, 50:107-116.
72. Del Priore L.V., Tezel T.H. Reattachment rate of human retinal pigment epithelium to layers of human Bruch's membrane. Arch. Ophthalmol. 1998, 116:335-341.
73. Sugino I.K., et al. Comparison of FRPE and human embryonic stem cell-derived RPE behavior on aged human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 2011, 52:4979-4997.
74. Li Y., Tang L. [Comparison of growth of human fetal RPE cells on electrospun nanofibers and etched pore polyester membranes]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2012, 37:433-440. (in Chinese).
75. Stanzel B.V., et al. Subretinal delivery of ultrathin rigid-elastic cell carriers using a metallic shooter instrument and biodegradable hydrogel encapsulation. Invest. Ophthalmol. Vis. Sci. 2012, 53:490-500.
76. Hu Y., et al. A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Res. 2012, 48:186-191.
77. Kearns V., et al. Plasma polymer coatings to aid retinal pigment epithelial growth for transplantation in the treatment of age related macular degeneration. J. Mater. Sci. Mater. Med. 2012, 23:2013-2021.
78. Subrizi A., et al. Generation of hESC-derived retinal pigment epithelium on biopolymer coated polyimide membranes. Biomaterials 2012, 33:8047-8054.
79. Schwartz S.D., et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012, 379:713-720.
80. Okita K., Yamanaka S. Induced pluripotent stem cells: opportunities and challenges. Philos. Trans. R. Soc. Lond. B 2011, 366:2198-2207.
81. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
82. Takahashi K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
83. Yu J., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
84. Park I.H., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
85. Carr A.J., et al. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS ONE 2009, 4:e8152.
86. Krohne T.U., et al. Generation of retinal pigment epithelial cells from small molecules and OCT4-reprogrammed human induced pluripotent stem cells. Stem Cells Transl. Med. 2012, 1:96-109.
87. Meyer J.S., et al. Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells 2011, 29:1206-1218.
88. Westenskow P.D., et al. Using flow cytometry to compare the dynamics of photoreceptor outer segment phagocytosis in iPS-derived RPE cells. Invest. Ophthalmol. Vis. Sci. 2012, 53:6282-6290.
89. Kokkinaki M., et al. Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE. Stem Cells 2011, 29:825-835.
90. Zhao T., et al. Immunogenicity of induced pluripotent stem cells. Nature 2011, 474:212-215.
91. Liu Y., et al. The gene expression profiles of induced pluripotent stem cells (iPSCs) generated by a non-integrating method are more similar to embryonic stem cells than those of iPSCs generated by an integrating method. Genet. Mol. Biol. 2012, 35:693-700.
92. Fusaki N., et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad. Ser. B: Phys. Biol. Sci. 2009, 85:348-362.
93. Warren L., et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010, 7:618-630.
94. Kim D., et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4:472-476.
95. Medeiros N.E., Curcio C.A. Preservation of ganglion cell layer neurons in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2001, 42:795-803.
96. Humayun M.S., et al. Human neural retinal transplantation. Invest. Ophthalmol. Vis. Sci. 2000, 41:3100-3106.
97. Radtke N.D., et al. Vision change after sheet transplant of fetal retina with retinal pigment epithelium to a patient with retinitis pigmentosa. Arch. Ophthalmol. 2004, 122:1159-1165.
98. MacLaren R.E., et al. Retinal repair by transplantation of photoreceptor precursors. Nature 2006, 444:203-207.
99. Pearson R.A., et al. Restoration of vision after transplantation of photoreceptors. Nature 2012, 485:99-103.
100. Schmitt S., et al. Molecular characterization of human retinal progenitor cells. Invest. Ophthalmol. Vis. Sci. 2009, 50:5901-5908.
101. Aftab U., et al. Growth kinetics and transplantation of human retinal progenitor cells. Exp. Eye Res. 2009, 89:301-310.
102. Wohl S.G., et al. Neurogenic potential of stem/progenitor-like cells in the adult mammalian eye. Prog. Retin. Eye Res. 2012, 31:213-242.
103. Gust J., Reh T.A. Adult donor rod photoreceptors integrate into the mature mouse retina. Invest Ophthalmol Vis Sci 2011, 52:5266-5372.
104. Lamba D.A., et al. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:12769-12774.
105. Hirami Y., et al. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci. Lett. 2009, 458:126-131.
106. Mellough C.B., et al. Efficient stage-specific differentiation of human pluripotent stem cells toward retinal photoreceptor cells. Stem Cells 2012, 30:673-686.
107. Banin E., et al. Retinal incorporation and differentiation of neural precursors derived from human embryonic stem cells. Stem Cells 2006, 24:246-257.
108. Eiraku M., et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 2011, 472:51-56.
109. Nakano T., et al. Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 2012, 10:771-785.